Welcome industry leaders Doug Bain and Joe Dustin to the Curebase advisory team!

‍

As Curebase continues to grow and evolve our modern, user-friendly eClinical platform, Doug and Joe bring invaluable experience and insight that will help guide our eClinical innovation.

‍

Doug Bain: Clinical Trial Data Innovation Veteran

‍

Doug Bain brings over 30 years of leadership in clinical research technology. Most recently serving as Chief Technology Officer at KCR CRO, Doug has been shaping the landscape of EDC systems and clinical platforms since 1996.

He is currently leading ClinFlo Consulting, focused on the support and application of good technology for clinical research.

"Clinical trial technologies have grown increasingly complex, often at the expense of the user experience. What drew me to Curebase is their focus on reversing that trend—building a platform that is not only highly configurable and functionally robust, but also genuinely intuitive to use. I’m working with the team to ensure Curebase delivers best-of-breed functionality within a platform that meets the real-world needs of researchers, sites, and patients alike.”

‍

Joe Dustin: eClinical Technology Strategist

‍

Joe brings deep expertise, with over two decades of experience driving innovation and change management across Clinical Operations and Data Management.  He specializes in the eClinical technology stack (EDC, eCOA, IRT, CTMS, eSource, EHR, etc.). He has held senior leadership roles spanning Operations, Sales, and Product Strategy at industry-leading organizations including Medidata, Bristol Myers Squibb, Medable, and Biofourmis.

Joe currently leads Dauntless eClinical Strategies, advising Pharma companies, technology providers, investors, and executives on strategic technology initiatives and go-to-market planning.

“The industry needs more tech providers that are focused on building truly user-friendly tools. This is Curebase in a nutshell; they have always been building with UX in mind to provide simpler solutions to complex problems. I’m excited to contribute to a team that’s truly modernizing how clinical trials are run.”

‍

‍

Strengthening Curebase’s Growth

‍

Bringing Doug and Joe onto the advisory team comes at a pivotal time as we continue to expand platform capabilities and need their input to build the most modern, user-friendly software in the industry. 

‍

“I’m incredibly excited to welcome Doug Bain and Joe Dustin to the Curebase advisory team," said Curebase CEO Storm Stillman. "These two bring decades of insight at the intersection of tech and clinical operations and their impact is already being felt. Their combined experience is going to help us build smarter, more intuitive tools for the teams actually running trials. Looking forward to what we’ll create together.”